Thymmune is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.

Stan Wang

Founder & CEO,
Thymmune

Categories

Co-investors

Hansjorg Wyss, NYBC, John Maraganore and Phil Reilly

Stage at Investment

University

Harvard